NewAmsterdam Pharma Company
NAMS
#4452
Rank
C$2.59 B
Marketcap
$28.11
Share price
0.55%
Change (1 day)
105.61%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Cash on Hand

Cash on Hand as of September 2024 : C$0.59 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company has C$0.59 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

NewAmsterdam Pharma Company - Cash on Hand chart (from 2023 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$0.45 B-33.67%
2022-12-31C$0.68 B684.7%
2021-12-31C$86.75 M472.16%
2020-12-31C$15.16 M